Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1645
This examiner grants 75% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18681457 | GENETICALLY ENGINEERED CELL-DERIVED VACCINES | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18247084 | METHODS FOR REDUCING HOST CELL PROTEIN CONTENT IN PROTEIN PURIFICATION PROCESSES | Final Rejection | Eli Lilly and Company |
| 18505399 | ANTIFUNGAL AGENT | Final Rejection | Murata Manufacturing Co., Ltd. |
| 19144202 | MICROORGANISMS INTRODUCED WITH EXOGENOUS SOLUBLE PYRIDINE NUCLEOTIDE TRANSHYDROGENASE AND METHOD FOR PRODUCING L-TRYPTOPHAN USING THE SAME | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 18286030 | OFATUMUMAB FOR TREATING MULTIPLE SCLEROSIS IN ASIAN PATIENTS | Non-Final OA | Novartis AG |
| 18582346 | COMPOSITIONS AND METHODS FOR FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY BIOMARKER DETECTION | Non-Final OA | University of Washington |
| 18557721 | METHODS FOR THE ADMINISTRATION OF ADAMTS BINDING IMMUNOGLOBULINS | Final Rejection | Sanofi |
| 18285920 | A MULTIPLEX ASSAY FOR THE DIAGNOSIS OF BRUCELLA CANIS INFECTION | Non-Final OA | CORNELL UNIVERSITY |
| 18471422 | Compositions and Methods to Enhance Therapeutic Efficacy of Cancer Therapies | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18035908 | COMPOSITIONS AND METHODS FOR ENHANCING T CELL PENETRATION OF TUMORS AND CANCERS | Non-Final OA | Georgetown University |
| 18844433 | IMMUNOGENIC COMPOSITIONS | Non-Final OA | GLAXOSMITHKLINE BIOLOGICALS SA |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy